Zydus recalls single lot of blood thinner warfarin

Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.

Zydus says it is recalling all of warfarin lot MM5767 with an expiration date of June 2014. The company says it has not received any reports of patient injury or harm.

Warfarin is a blood thinner widely used to prevent blood clots in patients with irregular heartbeats, or a history of heart attack. An overdose of could cause excessive bleeding and potentially be fatal.

The drugmaker says the affected products were distributed to wholesalers, retailers and mail order providers nationwide between November and December 2012.

Anyone with the product should stop selling or using it immediately and call 1-800-967-5952 to arrange its return to the manufacturer.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New blood thinner beats older drug for vein clots

Feb 20, 2013

(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...

Kcentra approved to stop severe bleeding in heart patients

Apr 30, 2013

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...

Recommended for you

FDA warning: men's testosterone drugs overused (Update)

Mar 03, 2015

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

Early benefit assessment increases transparency for study data

Mar 03, 2015

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products (AMNOG). AMNOG was primarily aimed at containing the increasing drug expenditure of the statutory health insurance ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.